AAAAAA
Results: 26-50/89
Authors:
COWBURN PJ
MCARTHUR JD
HILLIS WS
MCMURRAY JJV
DARGIE HK
CLELAND JGF
Citation: Pj. Cowburn et al., PULMONARY AND SYSTEMIC RESPONSES TO SUBSTANCE-P IN PATIENTS WITH HEART-FAILURE WITH AND WITHOUT PULMONARY-HYPERTENSION, Journal of the American College of Cardiology, 29(2), 1997, pp. 99676-99676
Authors:
CLELAND JGF
Citation: Jgf. Cleland, ANTICOAGULANT AND ANTIPLATELET THERAPY IN HEART-FAILURE, Current opinion in cardiology, 12(3), 1997, pp. 276-287
Authors:
CLELAND JGF
WALKER A
Citation: Jgf. Cleland et A. Walker, MEDICAL-TREATMENT FOR ANGINA THE MOST COST-EFFECTIVE OPTION, European heart journal, 18, 1997, pp. 35-42
Authors:
REMME WJ
CLELAND JGF
DARGIE H
ERDMANN E
FERRARI R
KJEKSHUS J
KOMAJDA M
POOLEWILSON PA
RIEGGER G
SOLERSOLER J
TAVAZZI L
SWEDBERG K
WAAGSTEIN F
Citation: Wj. Remme et al., THE TREATMENT OF HEART-FAILURE, European heart journal, 18(5), 1997, pp. 736-753
Authors:
CLELAND JGF
ERHARDT L
MURRAY G
HALL AS
BALL SG
Citation: Jgf. Cleland et al., EFFECT OF RAMIPRIL ON MORBIDITY AND MODE OF DEATH AMONG SURVIVORS OF ACUTE MYOCARDIAL-INFARCTION WITH CLINICAL-EVIDENCE OF HEART-FAILURE - A REPORT FROM THE AIRE STUDY INVESTIGATORS, European heart journal, 18(1), 1997, pp. 41-51
Authors:
CLELAND JGF
Citation: Jgf. Cleland, ADVERSE EVENT WITH FIRST-DOSE PERINDOPRIL IN CONGESTIVE-HEART-FAILURE, Lancet, 350(9076), 1997, pp. 520-521
Authors:
CLELAND JGF
ERHARDT L
Citation: Jgf. Cleland et L. Erhardt, AMIODARONE AFTER MYOCARDIAL-INFARCTION - EMIAT AND CAMIAT TRIALS, Lancet, 349(9067), 1997, pp. 1767-1767
Authors:
CLELAND JGF
COWBURN PJ
MORGAN K
Citation: Jgf. Cleland et al., NEUROENDOCRINE ACTIVATION AFTER MYOCARDIAL-INFARCTION - CAUSES AND CONSEQUENCES, HEART, 76(3), 1996, pp. 53-59
INHALATION OF NITRIC-OXIDE IMPROVES THE CARDIAC-OUTPUT RESPONSE TO EXERCISE IN CHRONIC HEART-FAILURE
Authors:
PURI S
BAKER PL
DUTKA DP
OAKLEY CM
HUGHES JMB
CLELAND JGF
Citation: S. Puri et al., INHALATION OF NITRIC-OXIDE IMPROVES THE CARDIAC-OUTPUT RESPONSE TO EXERCISE IN CHRONIC HEART-FAILURE, HEART, 75(5), 1996, pp. 135-135
Authors:
CLELAND JGF
WARD S
DUTKA D
HABIB F
IMPALLOMENI M
MORTON IJ
Citation: Jgf. Cleland et al., STABILITY OF PLASMA-CONCENTRATIONS OF N-TERMINAL AND C-TERMINAL ATRIAL NATRIURETIC PEPTIDES AT ROOM-TEMPERATURE, HEART, 75(4), 1996, pp. 410-413
Authors:
CLELAND JGF
POOLEWILSON P
Citation: Jgf. Cleland et P. Poolewilson, IS ASPIRIN SAFE IN HEART-FAILURE - MORE DATA, HEART, 75(4), 1996, pp. 426-426
Authors:
CLELAND JGF
DUTKA DP
WARD S
OLIVOTTO I
IMPALLOMENI M
OAKLEY CM
Citation: Jgf. Cleland et al., EFFECTS OF ENALAPRIL ON CLINICAL, NONINVASIVE HEMODYNAMIC AND NEUROENDOCRINE INDEXES IN ELDERLY PATIENTS (AGED GREATER-THAN-75 YEARS) WITH HEART-FAILURE, Cardiology in the elderly, 4(4), 1996, pp. 131-137
Authors:
CLELAND JGF
HABIB P
Citation: Jgf. Cleland et P. Habib, ASSESSMENT AND DIAGNOSIS OF HEART-FAILURE, Journal of internal medicine, 239(4), 1996, pp. 317-325
Authors:
CLELAND JGF
MORGAN K
Citation: Jgf. Cleland et K. Morgan, INHIBITION OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HEART-FAILURE - NEW INSIGHTS FROM BASIC CLINICAL RESEARCH, Current opinion in cardiology, 11(3), 1996, pp. 252-262
Authors:
CLELAND JGF
Citation: Jgf. Cleland, CAN IMPROVED QUALITY OF CARE REDUCE THE COSTS OF MANAGING ANGINA-PECTORIS, European heart journal, 17, 1996, pp. 29-40
Authors:
NARANG R
CLELAND JGF
ERHARDT L
BALL SG
COATS AJS
COWLEY AJ
DARGIE HJ
HALL AS
HAMPTON JR
POOLEWILSON PA
Citation: R. Narang et al., MODE OF DEATH IN CHRONIC HEART-FAILURE - A REQUEST AND PROPOSITION FOR MORE ACCURATE CLASSIFICATION, European heart journal, 17(9), 1996, pp. 1390-1403
Authors:
COWBURN P
CLELAND JGF
Citation: P. Cowburn et Jgf. Cleland, SPAF-III RESULTS, European heart journal, 17(7), 1996, pp. 1129-1129
Authors:
CLELAND JGF
COWBURN PJ
FALK RH
Citation: Jgf. Cleland et al., SHOULD ALL PATIENTS WITH ATRIAL-FIBRILLATION RECEIVE WARFARIN - EVIDENCE FROM RANDOMIZED CLINICAL-TRIALS, European heart journal, 17(5), 1996, pp. 674-681
Authors:
CLELAND JGF
BRISTOW MR
ERDMANN E
REMME WJ
SWEDBERG K
WAAGSTEIN F
Citation: Jgf. Cleland et al., BETA-BLOCKING-AGENTS IN HEART-FAILURE - SHOULD THEY BE USED AND HOW, European heart journal, 17(11), 1996, pp. 1629-1639
Authors:
NARANG R
SWEDBERG K
CLELAND JGF
Citation: R. Narang et al., WHAT IQ THE IDEAL STUDY DESIGN FOR EVALUATION OF TREATMENT FOR HEART-FAILURE - INSIGHTS FROM TRIALS ASSESSING THE EFFECT OF ACE-INHIBITORS ON EXERCISE CAPACITY, European heart journal, 17(1), 1996, pp. 120-134
Authors:
CLELAND JGF
SWEDBERG K
Citation: Jgf. Cleland et K. Swedberg, CARVEDILOL FOR HEART-FAILURE, WITH CARE, Lancet, 347(9010), 1996, pp. 1199-1201
Authors:
COWBURN PJ
HILLIER C
CLELAND JGF
MCMURRAY JJ
BEATTIE E
MACMILLAN J
MORTON JJ
DARGIE HJ
MCGRATH JC
Citation: Pj. Cowburn et al., IMPAIRED VASOCONSTRICTION TO ENDOTHELIN-1 IN SMALL ARTERIES FROM PATIENTS WITH CONGESTIVE-HEART-FAILURE, Circulation, 94(8), 1996, pp. 428-428
Authors:
CLELAND JGF
Citation: Jgf. Cleland, FROM LEFT-VENTRICULAR DYSFUNCTION TO HEART-FAILURE, Archives des maladies du coeur et des vaisseaux, 89(11), 1996, pp. 1397-1402
Authors:
JIANG BY
HABIB F
OAKLEY CM
CLELAND JGF
Citation: By. Jiang et al., SHORTENED DURATION OF POSTISCHEMIC HYPEREMIC BLOOD-FLOW IN THE FOREARM OF PATIENTS WITH HEART-FAILURE, The American journal of cardiology, 77(4), 1996, pp. 300
Authors:
DUTKA DP
OLIVOTTO I
WARD S
OAKLEY CM
IMPALLOMENI M
CLELAND JGF
Citation: Dp. Dutka et al., EFFECTS OF AGING ON NEUROENDOCRINE ACTIVATION IN SUBJECTS AND PATIENTS IN THE PRESENCE AND ABSENCE OF HEART-FAILURE WITH LEFT-VENTRICULAR SYSTOLIC, The American journal of cardiology, 77(14), 1996, pp. 1197-1201